Viewing Study NCT00044512


Ignite Creation Date: 2025-12-26 @ 11:12 PM
Ignite Modification Date: 2025-12-26 @ 11:12 PM
Study NCT ID: NCT00044512
Status: COMPLETED
Last Update Posted: 2014-04-16
First Post: 2002-08-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-08
Start Date Type: None
Primary Completion Date: 2008-02
Primary Completion Date Type: ACTUAL
Completion Date: 2008-02
Completion Date Type: ACTUAL
First Submit Date: 2002-08-30
First Submit QC Date: None
Study First Post Date: 2002-09-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2009-02-20
Results First Submit QC Date: None
Results First Post Date: 2009-08-06
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-03-26
Last Update Post Date: 2014-04-16
Last Update Post Date Type: ESTIMATED